Donor risk factors, retrieval technique, preservation and ischemia/reperfusion injury in pancreas transplantation

Current Opinion in Organ Transplantation

Volumn 18, Issue 1, 2013, Pages 83-88

  Maglione, Manuel ^a   Ploeg, Rutger J ^a,b   Friend, Peter J ^a,b  

^a CHURCHILL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

DCD; ischemia; nonstandard donor; pancreas transplantation; risk score

Indexed keywords

AMYLASE; ANTITHROMBIN; CELSIOR; HTK SOLUTION; RECOMBINANT P SELECTIN ANTAGONIST; RECOMBINANT PROTEIN; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG; UNIVERSITY OF WISCONSIN SOLUTION;

AMYLASE BLOOD LEVEL; ANASTOMOSIS; BODY MASS; COLD ISCHEMIA; DRUG MEGADOSE; GASTRODUODENAL ARTERY; GRAFT FAILURE; GRAFT SURVIVAL; HEART DEATH; HUMAN; INCIDENCE; INFERIOR MESENTERIC ARTERY; INTESTINE GRAFT; KIDNEY TRANSPLANTATION; ORGAN DONOR; ORGAN PRESERVATION; PANCREAS BLOOD FLOW; PANCREAS TRANSPLANTATION; PROPHYLAXIS; RAPID DISSECTION; REPERFUSION INJURY; REVIEW; RISK FACTOR; SPLEEN ARTERY; SUPERIOR MESENTERIC ARTERY; SUPERIOR MESENTERIC VEIN; SURGEON; SURGICAL TECHNIQUE; THROMBOSIS; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; WARM DISSECTION;

AGE FACTORS; DONOR SELECTION; GRAFT SURVIVAL; HUMANS; ORGAN PRESERVATION; PANCREAS TRANSPLANTATION; REPERFUSION INJURY; RISK FACTORS; TISSUE AND ORGAN HARVESTING; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS;

EID: 84872967944     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e32835c29ef     Document Type: Review

References (64)

1. White SA, Shaw JA, Sutherland DE. Pancreas transplantation. Lancet 2009; 373:1808-1817.
2. Banga N, Hadjianastassiou VG, Mamode N, et al. Outcome of surgical complications following simultaneous pancreas-kidney transplantation. Nephrol Dial Transplant 2012; 27:1658-1663.
3. Page M, Rimmelé T, Ber CE, et al. Early relaparotomy after simultaneous pancreas-kidney transplantation. Transplantation 2012; 94:159-164.
4. Gruessner AC. 2011 update on pancreas transplantation: comprehensive trend analysis of 25, 000 cases followed up over the course of twenty-four years at the International Pancreas Transplant Registry (IPTR). Rev Diabet Stud 2011; 8:6-16.
5. Tuttle-Newhall JE, Krishnan SM, Levy MF, et al. Organ donation and utilization in the United States: 1998-2007. Am J Transplant 2009; 9:879-893.
6. Muthusamy AS, Mumford L, Hudson A, et al. Pancreas transplantation from donors after circulatory death from the United kingdom. Am J Transplant 2012; 12:2150-2156.
7. Vinkers MT, Rahmel AO, Slot MC, et al. How to recognize a suitable pancreas donor: a Eurotransplant study of preprocurement factors. Transplant Proc 2008; 40:1275-1278.
8. Sutherland D, Gruessner R, Dunn D, et al. Lessons learned from more than 1, 000 pancreas transplants at a single institution. Ann Surg 2001; 233:463-501.
9. Fridell JA, Rogers J, Stratta RJ. The pancreas allograft donor: current status, controversies, and challenges for the future. Clin Transplant 2010; 24:433-449.
10. Gruessner AC, Sutherland DE, Gruessner RW. Long-term outcome after pancreas transplantation. Curr Opin Organ Transplant 2012; 17:100-105.
11. Vinkers MT, Rahmel AO, Slot MC, et al. Influence of a donor quality score on pancreas transplant survival in the Eurotransplant area. Transplant Proc 2008; 40:3606-3608.
12. Woeste G, Moench C, Hauser IA, et al. Can the preprocurement pancreas suitability score predict ischemia-reperfusion injury and graft survival after pancreas transplantation? Transplant Proc 2010; 42:4202-4205.
13. Schenker P, Vonend O, Ertas N, et al. Preprocurement pancreas allocation suitability score does not correlate with long-term pancreas graft survival. Transplant Proc 2010; 42:178-180.
14. Foltys DB, Kaths JM, Zimmermann T, et al. Ten years of simultaneous pancreas-kidney transplantation: a retrospective single-center analysis of prospectively obtained data. Transplant Proc 2011; 43:3267-3269.
15. Axelrod DA, Sung RS, Meyer KH, et al. Systematic evaluation of pancreas allograft quality, outcomes and geographic variation in utilization. Am J Transplant 2010; 10:837-845.
16. Singh RP, Rogers J, Farney AC, et al. Outcomes of extended donors in pancreatic transplantation with portal-enteric drainage. Transplant Proc 2008; 40:502-505.
17. Salvalaggio PR, Schnitzler MA, Abbott KC, et al. Patient and graft survival implications of simultaneous pancreas kidney transplantation from old donors. Am J Transplant 2007; 7:1561-1571.
18. Boggi U, Del Chiaro M, Signori S, et al. Pancreas transplants from donors aged 45 years or older. Transplant Proc 2005; 37:1265-1267.
19. Fernandez LA, Turgeon NA, Odorico JS, et al. Superior long-term results of simultaneous pancreas-kidney transplantation from pediatric donors. Am J Transplant 2004; 4:2093-2101.
20. Fridell JA, Mangus RS, Taber TE, et al. Growth of a nation part I: impact of organ donor obesity on whole-organ pancreas transplantation. Clin Transplant 2011; 25:E225-E232.
21. Doḿinguez-Gil B, Haase-Kromwijk B, Van Leiden H, et al. Current situation of donation after circulatory death in European countries. Transpl Int 2011; 24:676-686.
22. Qureshi MS, Callaghan CJ, Bradley JA, et al. Outcomes of simultaneous pancreas-kidney transplantation from brain-dead and controlled circulatory death donors. Br J Surg 2012; 99:831-838.
23. Bellingham JM, Santhanakrishnan C, Neidlinger N, et al. Donation after cardiac death: a 29-year experience. Surgery 2011; 150:692-702.
24. Brockmann JG, Vaidya A, Reddy S, Friend PJ. Retrieval of abdominal organs for transplantation. Br J Surg 2006; 93:133-146.
25. Wunderlich H, Brockmann JG, Voigt R, et al. DTG procurement guidelines in heart beating donors. Transpl Int 2011; 24:733-757.
26. Klar E, Kraus T, Osswald BR, et al. Induction of impaired hepatic micro-circulation by in situ hilus preparation in liver explantation. Zentralbl Chir 1995; 120:482-485.
27. Hevelke P, Grodzicki M, Nyckowski P, et al. Hepatic artery reconstruction prior to orthotopic liver transplantation. Transplant Proc 2003; 35:2253-2255.
28. Boggi U, Vistoli F, Del Chiaro M, et al. A simplified technique for the en bloc procurement of abdominal organs that is suitable for pancreas and small-bowel transplantation. Surgery 2004; 135:629-641.
29. Fridell JA, Mangus RS, Powelson JA, et al. Outcomes of pancreas allografts procured simultaneously with an isolated intestine allograft: single-center and national data. Transplantation 2012; 94:84-88.
30. Reich DJ, Mulligan DC, Abt PL, et al. ASTS recommended practice guidelines for controlled donation after cardiac death organ procurement and transplantation. Am J Transplant 2009; 9:2004-2011.
31. Moers C, Smits J, Maathuis M, et al. Machine perfusion or cold storage in deceased-donor kidney transplantation. N Engl J Med 2009; 360:7-19.
32. Guarrera JV, Henry SD, Samstein B, et al. Hypothermic machine preservation in human liver transplantation: the first clinical series. Am J Transplant 2010; 10:372-381.
33. Maathuis MH, Leuvenink HG, Ploeg RJ. Perspectives in organ preservation. Transplantation 2007; 83:1289-1298.
34. Fridell JA, Mangus RS, Powelson JA. Organ preservation solutions for whole organ pancreas transplantation. Curr Opin Organ Transplant 2011; 16:116-122.
35. Ploeg RJ, Goossens D, Sollinger HW, et al. The Belzer-UW solution for effective long-term preservation in canine pancreas transplantation. Transplant Proc 1989; 21:1378-1380.
36. Bretschneider HJ. Myocardial protection. Thorac Cardiovasc Surg 1980; 28:295-302.
37. Menasché P, Termignon JL, Pradier F, et al. Experimental evaluation of Celsior, a new heart preservation solution. Eur J Cardiothorac Surg 1994; 8:207-213.
38. Iwanaga Y, Sutherland DE, Harmon JV, Papas KK. Pancreas preservation for pancreas and islet transplantation. Curr Opin Organ Transplant 2008; 13:445-451.
39. Squifflet JP, LeDinh H, de Roover A, Meurisse M. Pancreas preservation for pancreas and islet transplantation: a minireview. Transplant Proc 2011; 43:3398-3401.
40. Fridell JA, Mangus RS, Powelson JA. Histidine-tryptophan-ketoglutarate for pancreas allograft preservation: the Indiana University experience. Am J Transplant 2010; 10:1284-1289.
41. Potdar S, Malek S, Eghtesad B, et al. Initial experience using histidine-tryptophan-ketoglutarate solution in clinical pancreas transplantation. Clin Transplant 2004; 18:661-665.
42. Becker T, Ringe B, Nyibata M, et al. Pancreas transplantation with histidine-tryptophan-ketoglutarate (HTK) solution and University of Wisconsin (UW) solution: is there a difference? JOP 2007; 8:304-311.
43. Schneeberger S, Biebl M, Steurer W, et al. A prospective randomized multicenter trial comparing histidine-tryptophane-ketoglutarate versus University of Wisconsin perfusion solution in clinical pancreas transplantation. Transpl Int 2009; 22:217-224.
44. Stewart Z, Cameron A, Singer A, et al. Histidine-tryptophan-ketoglutarate (HTK) is associated with reduced graft survival in pancreas transplantation. Am J Transplant 2009; 9:217-221.
45. Alonso D, Dunn T, Rigley T, et al. Increased pancreatitis in allografts flushed with histidine-tryptophan-ketoglutarate solution: a cautionary tale. Am J Transplant 2008; 8:1942-1945.
46. Boggi U, Vistoli F, Del Chiaro M, et al. Pancreas preservation with University of Wisconsin and Celsior solutions: a single-center, prospective, randomized pilot study. Transplantation 2004; 77:1186-1190.
47. Manrique A, Jimé nez C, Herrero ML, et al. Pancreas preservation with the University of Wisconsin versus Celsior solutions. Transplant Proc 2006; 38:2582-2584.
48. Warshaw AL, O'Hara PJ. Susceptibility of the pancreas to ischemic injury in shock. Ann Surg 1978; 188:197-201.
49. Fernández-del Castillo C, Harringer W, Warshaw AL, et al. Risk factors for pancreatic cellular injury after cardiopulmonary bypass. N Engl J Med 1991; 325:382-387.
50. Schaser K, Puhl G, Vollmar B, et al. In vivo imaging of human pancreatic microcirculation and pancreatic tissue injury in clinical pancreas transplantation. Am J Transplant 2005; 5:341-350.
51. Drognitz O, Obermaier R, Liu X, et al. Effects of organ preservation, ischemia time and caspase inhibition on apoptosis and microcirculation in rat pancreas transplantation. Am J Transplant 2004; 4:1042-1050.
52. Maglione M, Oberhuber R, Cardini B, et al. Donor pretreatment with tetra-hydrobiopterin saves pancreatic isografts from ischemia reperfusion injury in a mouse model. Am J Transplant 2010; 10:2231-2240.
53. Hegyi P, Rakonczay Z. The role of nitric oxide in the physiology and patho-physiology of the exocrine pancreas. Antioxid Redox Signal 2011; 15:2723-2741.
54. Hackert T, Werner J, Uhl W, et al. Reduction of ischemia/reperfusion injury by antithrombin III after experimental pancreas transplantation. Am J Surg 2005; 189:92-97.
55. Preissler G, Eichhorn M, Waldner H, et al. Intercellular adhesion molecule-1 blockade attenuates inflammatory response and improves microvascular perfusion in rat pancreas grafts. Pancreas 2012; 41:1112-1118.
56. Fertmann JM, Arbogast HP, Illner WD, et al. Antithrombin therapy in pancreas retransplantation and pancreas-after-kidney/pancreas-transplantation- alone patients. Clin Transplant 2011; 25:E499-508.
57. Gaber AO, Mulgaonkar S, Kahan BD, et al. YSPSL (rPSGL-Ig) for improvement of early renal allograft function: a double-blind, placebo-controlled, multicenter Phase IIa study. Clin Transplant 2011; 25:523-533.
58. Cheadle C, Watkins T, Ehrlich E, et al. Effects of antiadhesive therapy on kidney biomarkers of ischemia reperfusion injury in human deceased donor kidney allografts. Clin Transplant 2011; 25:766-775.
59. Cheung MM, Kharbanda RK, Konstantinov IE, et al. Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery: first clinical application in humans. J Am Coll Cardiol 2006; 47:2277-2282.
60. Oehmann C, Benz S, Drognitz O, et al. Remote preconditioning reduces microcirculatory disorders in pancreatic ischemia/reperfusion injury. Pancreas 2007; 35:e45-e50.
61. Nikeghbalian S, Mardani P, Mansoorian MR, et al. The effect of ischemic preconditioning of the pancreas on severity of ischemia/reperfusion-induced pancreatitis after a long period of ischemia in the rat. Transplant Proc 2009; 41:2743-2746.
62. Ojo AO, Meier-Kriesche HU, Hanson JA, et al. The impact of simultaneous pancreas-kidney transplantation on long-term patient survival. Transplantation 2001; 71:82-90.
63. Wolfe RA, McCullough KP, Schaubel DE, et al. Calculating life years from transplant (LYFT): methods for kidney and kidney-pancreas candidates. Am J Transplant 2008; 8 (4 Pt 2):997-1011.
64. Nathan DM, Fogel H, Norman D, et al. Long-term metabolic and quality of life results with pancreatic/renal transplantation in insulin-dependent diabetes mellitus. Transplantation 1991; 52:85-91.